Iso-Seq
The Iso-Seq method generates full-length cDNA sequences and analyzes full-length transcript isoforms.
Low-Pass Whole Genome Sequencing
Low-Pass Whole Genome Sequencing (LP-WGS or low-coverage whole-genome sequencing) is an inexpensive high-throughput technology for detecting genome-wide genetic variation in a multitude of species.
Cancer Panels
Cancer panels using next generation sequencing (NGS) technology target specific genes or mutations relevant to a particular cancer phenotype.
ChIP-Seq
ChIP-Seq (chromatin immunoprecipitation sequencing) combines the highly effective chromatin immunoprecipitation (ChIP) methodology and next generation sequencing (NGS) to analyze protein-DNA interactions.
ATAC-Seq
ATAC-Seq is a technique used to analyze the functional state of chromatin at the genome-wide level. The assay for transposase-accessible chromatin sequencing identifies regions of open chromatin and efficiently labels them for high-throughput sequencing.
Methylation Sequencing
Methylation sequencing is the process in which DNA methylation is quantified using sodium bisulfite and subsequent nucleotide base conversion. To uncover the methylome, GENEWIZ uses wet and dry lab solutions, including Methyl-Seq, for global whole genome and targeted 5-methylcytosine (5mC) detection.
Immuno-Profiling
Immune Profiling couples ultra-deep sequencing of V(D)J regions and customized bioinformatics to provide comprehensive characterization of the entire B-cell receptor (BCR) and T-cell receptor (TCR) repertoire.
Single-Cell RNA-Seq
Single-cell RNA-Seq (scRNA-Seq) provides transcriptional profiling of thousands of individual cells. As an early adopter of the 10x Genomics® Chromium™ and Illumina® NovaSeq™ 6000., GENEWIZ Multiomics & Synthesis Solutions from Azenta Life Sciences provides optimized scRNA-Seq workflows.
Clinical Genome Sequencing (CLIA / CAP)
Clinical Genome Sequencing provides a CLIA-validated comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Clinical Exome Sequencing (CLIA / CAP)
Clinical Exome Sequencing is a CLIA-validated method to probe protein-coding regions of the genome at high depth and with uniform coverage. Our regulatory service provides whole exome sequencing services in our GCP-compliant, CAP-accredited laboratory.